This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

EP Global Communications, Inc. Welcomes Stephen DeFelice, MD, To Advisory Board

JOHNSTOWN, Pa., Jan. 29 /PRNewswire-FirstCall/ -- EP Global Communications, Inc. (EPGL), (the Company), (Pink Sheets: EPGL), ( www.eparent.com), the parent company of Exceptional Parent ( EP) magazine, is proud to announce that Stephen L. DeFelice, MD, has joined the EPGL Advisory Board. Dr. DeFelice is one of the world's leading authorities on nutraceutical products and is credited for introducing the term "nutraceutical." 

"This addition to our team of experts will enable EPGL to more authoritatively evaluate and provide accurate and scientifically sound information about the multitude of products offered in the vast arena of nutraceuticals and indeed unique medical devices," stated the Company's President and CEO, Joseph M. Valenzano, Jr.  "EP Global Communications intends to use its multitude of relationships in the healthcare, pharmaceutical, and biotech industries and its impeccable reputation for science-based, credible information to objectively review those products which can have a positive effect on the lives of people with disabilities and special healthcare needs and their families and caregivers."  

Stephen L. DeFelice, MD is the Founder and Chairman of the Foundation for Innovation in Medicine (FIM), a nonprofit organization established in 1976 with the purpose of accelerating medical discovery by establishing a more productive clinical research community.  A graduate of Temple University, Dr. DeFelice received his MD from Jefferson Medical College in Philadelphia. He was a National Institute of Health (NIH) fellow in endocrinology, diabetes, and metabolic disease at Jefferson and a fellow in clinical pharmacology at St. Vincent's Hospital and Medical Center in New York City. Dr. DeFelice is the former Chief of Clinical Pharmacology at the Walter Reed Army Institute of Research (WRAIR). His 35-year experience with carnitine, a naturally occurring substance with multiple medical benefits, sparked his interest and determination to encourage medical discovery. His experience taught him that the promise of medical technology is exploding, but the barriers, costs, and risks of clinically testing their promise, a critical step in medical discovery, are also exploding.

In 1972, Dr. DeFelice wrote the book Drug Discovery: The Pending Crisis (Medcom Press) to alert the US to the fact that medical discovery was and would continue to be significantly delayed because of the formidable barriers to conducting clinical research. He first proposed the idea of physician volunteers or "doctornauts" (a term he coined) who would be more free than others to volunteer for clinical research. This simple act would lead to the clinical testing of more potential medical discoveries.

Today, FIM is involved in two initiatives: the Nutraceutical Research and Education Act (NREA) and the need for Congress to enact the Doctornaut Act. Senator Bill Frist (R-TN) has expressed a strong interest in the latter concept.

About EP Global Communications, Inc.

EP Global Communications, Inc., parent company of Exceptional Parent ( EP) magazine, is a 39-year-old, award-winning, multi-media publishing and communications company, providing timely and indispensable resources and information to families and professionals caring for the needs of children and adults with disabilities and special health care needs, including families in the U.S. Military.

Safe Harbor Statement

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

SOURCE EP Global Communications, Inc.

Copyright 2009 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
EPGL $0.06 0.00%
AAPL $109.10 -1.20%
FB $87.40 -0.85%
GOOG $600.60 -0.93%
TSLA $239.36 -2.50%

Markets

Chart of I:DJI
DOW 16,374.76 +23.38 0.14%
S&P 500 1,951.13 +2.27 0.12%
NASDAQ 4,733.4970 -16.4820 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs